Literature DB >> 19236900

Therapeutic potential of FOXP3(+) regulatory T cells and their interactions with dendritic cells.

Dat Q Tran1, Ethan M Shevach.   

Abstract

FOXP3(+) regulatory T cells, a unique subset of T cells, are critical for orchestrating an immune response and preventing self-reactivity. With the increasing prevalence and unsatisfactory treatment of autoimmunity, allergic diseases, cancer and chronic infections, much attention has been focused on understanding their mechanisms of action in order to manipulate their function. One goal is to develop drugs or biologics that can enhance or abrogate their functions. Another approach is to utilize Tregs in adoptive cell-based therapy to treat autoimmune diseases or transplant-related complications. This review will focus on their therapeutic potential and mechanisms of action, particularly their interaction with dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236900     DOI: 10.1016/j.humimm.2009.02.007

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  27 in total

1.  Perspectives on Regulatory T Cell Therapies.

Authors:  Michael Probst-Kepper; Andrea Kröger; Henk S P Garritsen; Jan Buer
Journal:  Transfus Med Hemother       Date:  2009-09-10       Impact factor: 3.747

2.  Overexpression of TGF-ß 1 gene induces cell surface localized glucose-regulated protein 78-associated latency-associated peptide/TGF-ß.

Authors:  Takatoku Oida; Howard L Weiner
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

Review 3.  Th17 cells and Tregs: unlikely allies.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  J Leukoc Biol       Date:  2014-02-21       Impact factor: 4.962

4.  Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells.

Authors:  Roopali Gandhi; Deepak Kumar; Evan J Burns; Meghan Nadeau; Ben Dake; Alice Laroni; Deneen Kozoriz; Howard L Weiner; Francisco J Quintana
Journal:  Nat Immunol       Date:  2010-08-01       Impact factor: 25.606

Review 5.  The role of regulatory T cells in atopic dermatitis.

Authors:  Rachana Agrawal; Julia A Wisniewski; Judith A Woodfolk
Journal:  Curr Probl Dermatol       Date:  2011-05-12

Review 6.  Oral tolerance.

Authors:  Howard L Weiner; Andre Pires da Cunha; Francisco Quintana; Henry Wu
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

Review 7.  Oral tolerance.

Authors:  Ana M C Faria; Howard L Weiner
Journal:  Immunol Rev       Date:  2005-08       Impact factor: 12.988

Review 8.  Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases.

Authors:  Franco Pandolfi; Rossella Cianci; Danilo Pagliari; Raffaele Landolfi; Giovanni Cammarota
Journal:  Mediators Inflamm       Date:  2010-02-08       Impact factor: 4.711

9.  FOXP3 and GARP (LRRC32): the master and its minion.

Authors:  Michael Probst-Kepper; Jan Buer
Journal:  Biol Direct       Date:  2010-02-05       Impact factor: 4.540

10.  Regulatory T cell microRNA expression changes in children with acute Kawasaki disease.

Authors:  F-F Ni; C-R Li; Q Li; Y Xia; G-B Wang; J Yang
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.